New antiarrhythmic agents for atrial fibrillation.
Conway
D S
DS
University Department of Medicine, City Hospital, Birmingham, UK.
Lip
G Y
GY
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D006827:Hydantoins; D007093:Imidazoles / Q000627:therapeutic use; D048289:Imidazolidines; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D006827:Hydantoins; D007093:Imidazoles; D048289:Imidazolidines; D010627:Phenethylamines; D010879:Piperazines; D013449:Sulfonamides; C067192:ibutilide; C086123:azimilide; D008012:Lidocaine; C042288:pilsicainide; C063533:dofetilide